Pyelonephritis (or pyelo) is a common infection of the kidneys that affects individuals of all ages. It is a potentially serious condition that can cause significant health problems if left untreated. In this comprehensive guide, we will discuss the causes, symptoms, diagnosis, and treatment of pyelo, as well as strategies for preventing and managing kidney health.
Pyelonephritis is an infection of the kidneys caused by bacteria. It can be either acute or chronic. Acute pyelonephritis is a sudden and severe infection that typically occurs in the lower urinary tract, while chronic pyelonephritis is a long-term infection that affects both the upper and lower urinary tract.
Pyelonephritis is typically caused by bacteria that travel from the bladder up into the kidneys. Common causes of pyelonephritis include E. coli, Klebsiella pneumonia, Staphylococcus aureus, and Proteus mirabilis. Other factors that increase the risk of developing pyelonephritis include bladder obstruction, poor hygiene, and weakened immune systems.
The most common symptoms of pyelonephritis include fever, chills, nausea, vomiting, abdominal pain, and a frequent urge to urinate. Other signs and symptoms may include cloudy or bloody urine, pain in the side or lower back, and fatigue.
Diagnosis of pyelonephritis usually begins with a physical exam and a review of the patient’s medical history. The doctor may also order urine tests, blood tests, or imaging tests to help confirm the diagnosis.
Treatment of pyelonephritis typically involves antibiotics. In some cases, hospitalization may be necessary for intravenous antibiotics. Additionally, the doctor may recommend lifestyle changes such as drinking plenty of fluids, avoiding alcohol and caffeine, and taking over-the-counter pain medications.
The best way to prevent pyelonephritis is to practice good hygiene. This includes washing hands regularly, urinating after intercourse, and avoiding contact with people who have urinary tract infections. Additionally, it is important to drink plenty of fluids and to avoid alcohol and caffeine.
In addition to preventing pyelonephritis, it is important to manage kidney health. This includes regular check-ups with the doctor, eating a balanced diet, and exercising regularly. It is also important to reduce stress and to get enough sleep.
Pyelonephritis is a common infection of the kidneys that can cause significant health problems if left untreated. In this comprehensive guide, we discussed the causes, symptoms, diagnosis, and treatment of pyelonephritis, as well as strategies for preventing and managing kidney health. By understanding the causes and symptoms of pyelonephritis and taking steps to prevent and manage kidney health, individuals can reduce their risk of developing this potentially serious condition.
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation